Entrectinib in locally advanced or metastatic ROS1 fusion-positive non-small cell lung cancer (NSCLC): Integrated analysis of ALKA-372-001, STARTRK-1 and STARTRK-2 Meeting Abstract
| Authors: | Drilon, A.; Barlesi, F.; De Braud, F.; Cho, B. C.; Ahn, M. J.; Siena, S.; Krebs, M. G.; Lin, C. C.; John, T.; Tan, D. S. W.; Seto, T.; Dziadziuszko, R.; Arkenau, H. T.; Rolfo, C.; Wolf, J.; Ye, C.; Riehl, T.; Eng, S.; Doebele, R. C. |
| Abstract Title: | Entrectinib in locally advanced or metastatic ROS1 fusion-positive non-small cell lung cancer (NSCLC): Integrated analysis of ALKA-372-001, STARTRK-1 and STARTRK-2 |
| Meeting Title: | 110th Annual Meeting of the American Association for Cancer Research (AACR) |
| Journal Title: | Cancer Research |
| Volume: | 79 |
| Issue: | 13 Suppl. |
| Meeting Dates: | 2019 Mar 29-Apr 3 |
| Meeting Location: | Atlanta, GA |
| ISSN: | 0008-5472 |
| Publisher: | American Association for Cancer Research |
| Date Published: | 2019-07-01 |
| Language: | English |
| ACCESSION: | WOS:000488129900171 |
| DOI: | 10.1158/1538-7445.Am2019-ct192 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: CT192 -- Source: Wos |
